Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Income Statement

Abbott Laboratories, common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net sales 100.00 100.00 100.00 100.00 100.00
Cost of products sold, excluding amortization of intangible assets -44.82 -43.85 -43.03 -43.35 -41.47
Amortization of intangible assets -4.90 -4.61 -4.75 -6.16 -6.07
Gross profit 50.28% 51.54% 52.21% 50.49% 52.46%
Research and development -6.83 -6.62 -6.37 -6.99 -7.65
Selling, general and administrative -27.30 -25.77 -26.29 -28.02 -30.61
Operating earnings 16.15% 19.16% 19.56% 15.48% 14.21%
Interest expense -1.59 -1.28 -1.24 -1.58 -2.10
Interest income 0.96 0.42 0.10 0.13 0.29
Net foreign exchange gain (loss) -0.10 0.00 0.00 0.02 -0.02
Debt extinguishment costs 0.00 0.00 0.00 0.00 -0.20
Other income (expense), net 1.19 0.74 0.64 0.30 0.60
Earnings from continuing operations before taxes 16.61% 19.03% 19.06% 14.36% 12.78%
Taxes on earnings from continuing operations -2.35 -3.15 -2.65 -1.44 -1.22
Earnings from continuing operations 14.27% 15.88% 16.42% 12.92% 11.56%
Net earnings from discontinued operations, net of taxes 0.00 0.00 0.00 0.07 0.00
Net earnings 14.27% 15.88% 16.42% 12.99% 11.56%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Operating earnings The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories operating earnings as a percentage of net sales decreased from 2021 to 2022 and from 2022 to 2023.
Earnings from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abbott Laboratories earnings from continuing operations before taxes as a percentage of net sales decreased from 2021 to 2022 and from 2022 to 2023.
Net earnings The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abbott Laboratories net earnings as a percentage of net sales decreased from 2021 to 2022 and from 2022 to 2023.